1. Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran.
Cell J. 2011 Fall;13(3):179-86. Epub 2011 Sep 23.
The clavulanic acid regulatory gene (claR) is in the clavulanic acid biosynthetic gene cluster that encodes ClaR. This protein is a putative regulator of the late steps of clavulanic acid biosynthesis. The aim of this research is the molecular cloning of claR, isolated from the Iranian strain of Streptomyces clavuligerus (S. clavuligerus).
In this experimental study, two different strains of S. clavuligerus were used (PTCC 1705 and DSM 738), of which there is no claR sequence record for strain PTCC 1705 in all three main gene banks. The specific designed primers were subjected to a few base modifications for introduction of the recognition sites of BamHI and ClaI. The claR gene was amplified by polymerase chain reaction (PCR) using DNA isolated from S. clavuligerus PTCC 1705. Nested-PCR, restriction fragment length polymorphism (PCR-RFLP), and sequencing were used for molecular analysis of the claR gene. The confirmed claR was subjected to double digestion with BamHI and ClaI. The cut claR was ligated into a pBluescript (pBs) vector and transformed into E. coli.
The entire sequence of the isolated claR (Iranian strain) was identified. The presence of the recombinant vector in the transformed colonies was confirmed by the colony-PCR procedure. The correct structure of the recombinant vector, isolated from the transformed E. coli, was confirmed using gel electrophoresis, PCR, and double digestion with restriction enzymes.
The constructed recombinant cassette, named pZSclaR, can be regarded as an appropriate tool for site directed mutagenesis and sub-cloning. At this time, claR has been cloned accompanied with its precisely selected promoter so it could be used in expression vectors. Hence the ClaR is known as a putative regulatory protein. The overproduced protein could also be used for other related investigations, such as a mobility shift assay.
克拉维酸调控基因(claR)位于克拉维酸生物合成基因簇中,该基因簇编码 ClaR。这种蛋白质是克拉维酸生物合成后期步骤的假定调节剂。本研究的目的是从伊朗链霉菌(Streptomyces clavuligerus)(S. clavuligerus)中分离出 claR 进行分子克隆。
在这项实验研究中,使用了两种不同的 S. clavuligerus 菌株(PTCC 1705 和 DSM 738),其中菌株 PTCC 1705 在所有三个主要基因库中都没有 claR 序列记录。设计的特异性引物进行了一些碱基修饰,以引入 BamHI 和 ClaI 的识别位点。使用从 S. clavuligerus PTCC 1705 中分离的 DNA 通过聚合酶链反应(PCR)扩增 claR 基因。嵌套 PCR、限制性片段长度多态性(PCR-RFLP)和测序用于 claR 基因的分子分析。确认的 claR 用 BamHI 和 ClaI 进行双酶切。切割的 claR 连接到 pBluescript(pBs)载体中并转化到大肠杆菌中。
鉴定出分离的 claR(伊朗株)的整个序列。通过菌落 PCR 程序确认转化菌落中存在重组载体。从转化的大肠杆菌中分离出的重组载体的正确结构通过凝胶电泳、PCR 和用限制性内切酶双重消化来确认。
构建的重组盒命名为 pZSclaR,可作为定点突变和亚克隆的合适工具。此时,已克隆带有精确选择启动子的 claR,可用于表达载体。因此,ClaR 被认为是一种假定的调节蛋白。过量表达的蛋白质也可用于其他相关研究,例如迁移率变动分析。